MEI Pharma Inc. has become the first U.S.-listed public company to adopt litecoin ( LTC) as a primary reserve asset, deploying $100 million from a recent stock sale to acquire 929,548 tokens of the cryptocurrency. Litecoin Creator Charlie Lee Joins MEI Pharma’s Board The clinical-stage biopharmaceutical company (Nasdaq: MEIP) disclosed the LTC acquisition in an […]Bitcoin NewsRead More
Related Posts
Quantum Challenge Offers a Single Bitcoin to Crack the Protocol’s Defense Mechanism
Luring quantum tinkerers, Project Eleven is dangling a one‑bitcoin bounty to whoever first demonstrates Bitcoin’s cryptographic Achilles’ heel using a quantum computer. Will a Single […]
Nigeria’s Oil-for-Naira Program, Blackrock’s New Stablecoin, and More — Week in Review
Nigeria introduced an “oil-for-naira” program by selling crude oil to Aliko Dangote’s refinery in a bid to stabilize the weakening local currency. Blackrock announced its […]
Ripple’s $5B Bid to Acquire Circle Gets Rejected: Report
Ripple has reportedly made a strategic acquisition attempt targeting competitor Circle Internet Group, offering between $4 billion and $5 billion. However, insiders revealed the offer […]
